Skip to main content
ICPE 2023 Main banner
Final Program


ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Video

Liver and Pregnancy Research Gone Viral

Saturday, August 26, 2023
8:00 AM – 9:30 AM ADT
Location:MR201

Presentations:

  • 8:00 AM – 8:15 AM ADT
    Comparative effectiveness and safety of apixaban and rivaroxaban in cirrhosis and atrial fibrillation

    Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital

  • 8:15 AM – 8:30 AM ADT
    Comparative effectiveness of non-selective beta blockers in cirrhosis

    Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital

  • 8:30 AM – 8:45 AM ADT
    Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

    Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

  • 8:45 AM – 9:00 AM ADT
    Association of Oral Direct-Acting Antiviral Therapy with Development of Parkinson's Disease in Patients with Chronic Hepatitis Virus

    Presenting Author: Pilar Hernandez-Con, MD, MSCE – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida

  • 9:00 AM – 9:15 AM ADT
    Comparative Effectiveness of the Levonorgestrel (LNG) Implant and Depot Medroxyprogesterone Acetate (DMPA) Injectable for Prevention of Pregnancy among Women Living with HIV on Efavirenz

    Presenting Author: Katie R. Mollan, MS (she/her/hers) – Gillings School of Global Public Health, University of North Carolina at Chapel Hill

  • 9:15 AM – 9:30 AM ADT
    Treating Genital Herpes Infection During Pregnancy to Reduce the Risk of Preeclampsia: A Prospective Cohort Study of more than 89,000 Pregnant Women

    Presenting Author: De-Kun Li, MD, PhD (he/him/his) – Division of Research, Kaiser Foundation Research Institute